Perfil
Thomas Littke is Head of Research and Development fro Speedel Pharma AG.
He joined Speedel in 2001 as Director of Clinical Operations.
Dr. Littke was a Senior Clinical Research Scientist at Takeda Corp., an International Medical Advisor at Novartis AG, and Director of Clinicaloperations at PRA International, Inc. He has experience in cardiovascular and metabolic diseases in the pharmaceutical industry.
Dr. Littke received an MD from the University of Freiburg, Germany.
Cargos activos de Thomas Littke
| Empresas | Cargo | Inicio |
|---|---|---|
Speedel Pharma AG
Speedel Pharma AG Pharmaceuticals: MajorHealth Technology Develops drugs for the treatment of cardiovascular and metabolic diseases | Director Técnico/Científico/I+D | - |
Antiguos cargos conocidos de Thomas Littke.
| Empresas | Cargo | Fin |
|---|---|---|
Takeda Corp.
Takeda Corp. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Corporate Officer/Principal | - |
| NOVARTIS AG | Corporate Officer/Principal | - |
Speedel Holding AG
Speedel Holding AG Pharmaceuticals: MajorHealth Technology Produces medicines | Corporate Officer/Principal | - |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 4 |
|---|---|
Novartis AG
Novartis AG Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Health Technology |
Takeda Corp.
Takeda Corp. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Health Technology |
Speedel Holding AG
Speedel Holding AG Pharmaceuticals: MajorHealth Technology Produces medicines | Health Technology |
Speedel Pharma AG
Speedel Pharma AG Pharmaceuticals: MajorHealth Technology Develops drugs for the treatment of cardiovascular and metabolic diseases | Health Technology |
- Bolsa de valores
- Insiders
- Thomas Littke
















